This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 236 Users Online

Impetigo Treatment Market

Impetigo Treatment Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2026

Impetigo Treatment Market Segmented By Route of Administration that is Oral, Topical, used in Specialty Clinics, Hospitals.

Impetigo Treatment: Market Insights

Impetigo is an acute bacterial skin infection which mainly affects children and infants. Impetigo is caused due to streptococcus or staphylococcus aureus. Impetigo appears as red scores and bumps blister on face especially around nose and mouth, hands and feet. Impetigo is a global disease affecting approximately 162 million worldwide

 Impetigo is a contagious disease which spreads through direct contact with the infected person. Impetigo is easy to treat with topical or oral antibiotics. Impetigo in adults is rare, however, minors are more prone to the disease. The sores are filled with pus which on scratching may spread to other parts of skin. Impetigo is treated with appropriate oral or tropical antibiotics which is directly applied to the sores.

Major focus is on product improvement and development of advanced ointments, lotions and pills, which will cure the disease at a faster rate. New medications restrict the reoccurrence of disease and improve the appearance of marks. Humidity and heat coupled with eczema develops the infection.

Impetigo are of two types: bullous impetigo involves large blisters and non-bullous impetigo or crusted impetigo. According to the American Academy of Family Physicians, incidence of impetigo in the U.K. accounts to 2.8% in children up to four years and 1.6% among children five to 15 years of age.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Impetigo Treatment: Market Dynamics

Impetigo is one of the most common bacterial skin disease which significantly increases the demand of its medication. Increasing incidence of impetigo in infant and children in the recent years is expected to fuel the market growth in the near future. Increase in infant population is expected to drive the market of impetigo treatment in the coming years.

Introduction of improved versions of topical and oral antibiotics that are cost-effective are the factors, which drive the overall impetigo treatment market over the forecast period. Risk of side effects of antibiotics treatment of impetigo is the major factor that hinders the growth of the global impetigo treatment market.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Impetigo Treatment Market: Segmentation

The global impetigo treatment market is segmented on basis of route of administration, end user and geography.

Route of Administration
  • Oral
  • Topical
End User
  • Specialty Clinics
  • Hospitals
  • Others


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Impetigo Treatment Market: Overview

On the basis of type of route of administration, the topical segment has a large revenue share owing to increase in adoption of topical treatment due to more effective results as compared to oral antibiotics which have limited adverse side effect. Also, oral antibiotics are nowadays gaining popularity as they give quick results in a short time period.

Based on end user, the Hospitals segment contributes a large revenue share among others, owing to increasing incidence of impetigo disease and increase in number of dermatologist in the end-use segment.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Impetigo Treatment Market: Region-wise Outlook

North America is expected to capture a large share in the global impetigo treatment market over the forecast period due to presence of large number of manufacturers in the region. Increasing incidence of impetigo infection in North America itself increase the demand for impetigo treatment.

Europe is expected to capture second large revenue share in the global impetigo treatment market. However, Asia Pacific is expected to register a fast growth during forecast period and is expected to be a profitable market for new players owing to the growing demand of medication for impetigo treatment.

Impetigo Treatment Market: Key Players

Examples of some of the key players present in the global impetigo treatment market are Medimetriks Pharmaceuticals, Inc., Aqua Pharmaceuticals, Teva Pharmaceutical Industries Ltd, and GlaxoSmithKline plc, among others.

 The report covers exhaustive analysis on:

  • Impetigo Treatment Market Segments
  • Impetigo Treatment Market Dynamics
  • Historical Actual Market Size, 2012 - 2016
  • Impetigo Treatment Market Size & Forecast 2016 to 2024
  • Impetigo Treatment Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Impetigo Treatment Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding China
  • China
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

- Companies Covered in This Report -

Google translate